When 2022 Tore Through the S&P 500, This Healthcare ETF Barely Flinched. Why Isn't It in More Retirement Accounts?24/7 Wall Street • 05/20/26
The Silver Tsunami: Healthcare ETFs to Buy Amid Aging US DemographicsZacks Investment Research • 05/13/26
Healthcare's Defensive Promise Crumbles: XLV Down 7% While SPY Rises 5% in 202624/7 Wall Street • 04/29/26
When the Market Sold Off in 2022, This Healthcare ETF Beat the S&P 500 by 16 Percentage Points. With Volatility Back, That History Is Worth Revisiting24/7 Wall Street • 04/25/26
The Stocks Goldman Sachs Thinks You Should Own as Iran War Stretches Into a Third WeekInvestopedia • 03/16/26
XLV is A $41 Billion Defensive Healthcare Play That Looks Good Until You Compare To The S&P 50024/7 Wall Street • 02/18/26